The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities.

The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities. Gynecol Oncol. 2018 Jan 31;: Authors: Moore KN, Mirza MR, Matulonis UA Abstract Niraparib is an oral poly(ADP ribose) polymerase (PARP) inhibitor that is currently approved by the United States Food and Drug Administration (US FDA) as well as recently approved by the European Medicines Agency (EMA) for the maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy. The mechanisms of action of niraparib include inhibition of PARP enzymatic activity as well as increased formation of PARP-DNA complexes through "trapping" the PARP enzyme on damaged DNA. Phase I and III studies have demonstrated activity and benefit of niraparib in both BRCA mutated (BRCAm) and BRCA wild-type (BRCAwt) cancers. Phase I testing of niraparib established the maximally tolerated dose of 300mg by mouth (PO) daily, and the phase 3 ENGOT-OV16/NOVA study demonstrated the benefit of niraparib maintenance therapy compared to placebo after completion of and response to platinum-based chemotherapy in both BRCAm and BRCAwt ovarian cancer patient populations. Toxicities seen with niraparib include hematologic, gastrointestinal, fatigue, and cardiovascular. Hematologic toxicities include thrombocytopenia, anemia, neutropenia and leukopenia; upfront dose modification to 200mg niraparib for patients with baseline weight of ≤77kg a...
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Tags: Gynecol Oncol Source Type: research

Related Links:

BOSTON (CBS) – Alex Fitzpatrick went from Hollywood screenwriter to Massachusetts restaurant owner so she and her husband could spend more time with her children. When she recently found out her risk of getting breast cancer was as high as 80%, all she could think of was her three boys. “I do want to make sure that I’m the one telling them what to wear on their wedding day and watch them go to college,” she said. Alex has one of the BRCA gene mutations. She got tested when an aunt was recently diagnosed with an aggressive form of breast cancer. “I was blindsided to be honest,” she remem...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated Local Watch Listen Angelina Jolie Breast Cancer Dr. Mallika Marshall Mass General Hospital Source Type: news
Republican opposition is building to a proposal from President Trump to lower drug prices in Medicare. The rare break between Trump and Republican allies follows an aggressive step from the president in October that would tie certain Medicare drug prices to lower prices in other countries, a departure from the traditional GOP position. (Peter Sullivan, The Hill)        
Source: The Commonwealth Fund: Publications - Category: International Medicine & Public Health Source Type: research
The dean of Yale's medical school, the incoming president of a prominent cancer group, and the head of a Texas cancer center are among those who have not accurately disclosed their ties with drug companies.ProPublica
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Internal Medicine News Source Type: news
(Reuters Health) - - Having a baby temporarily increases the risk of breast cancer by about 80 percent compared to the risk in women who have never given birth, researchers behind a new study have concluded.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
The U.S. Supreme Court on Monday rejected appeals by Louisiana and Kansas seeking to end their public funding to women's healthcare and abortion provider Planned Parenthood through the Medicaid program, with President Donald Trump's appointee Brett Kavanaugh among the justices who rebuffed the states.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news
(Reuters Health) - - When it's unclear whether the potential benefit of breast cancer screening outweighs the possible harms, doctors should encourage women to make an informed decision based on their personal preferences, Canadian doctors recommend.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Blake Nordstrom said he will undergo chemotherapy over the next few months in Seattle. Doctors have told him he can continue to work throughout this process.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news
There are more than enough conferences focused on aging and the treatment of aging these days to collectively be called a conference circuit, I think. A researcher in the field of aging could find two or more scientific events every month to attend, and the business side of conference hosting is catching up. I had to give up noting every event of interest a number of years ago for the sake of space, and I know of at least one individual who provides a service to the community by maintaining what is becoming quite a lengthy calendar of conferences. That there are more conferences rather than fewer conferences is a si...
Source: Fight Aging! - Category: Research Authors: Tags: Healthy Life Extension Community Source Type: blogs
Many people who are diagnosed with cancer will undergo some type of surgery to treat their disease — almost 95 percent of people with early-diagnosed breast cancer will require surgery and it’s often the first line of treatment for people with brain tumors, for example. But despite improvements in surgical techniques over the past decade, the cancer often comes back after the procedure.Now, a UCLA-led research team has developed a spray gel embedded with immune-boosting drugs that could help. In a peer-reviewed study, the substance was successful half of the time in awakening lab animals ’ immune systems ...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Anemia | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | European Medicines Agency (EMA) | Food and Drug Administration (FDA) | Gastroenterology | Heart | Hematology | Hypertension | Immunotherapy | Leukemia | Myelodysplastic Syndrome | Oral Cancer | Ovarian Cancer | Ovaries | Study | Thrombocytopenia | Toxicology | USA Health | Women